subscribeSubscribe
price-trendAsk Us
Acer Receives Notice of Allowance of Key US Patent Application Covering EDSIVO

Acer Receives Notice of Allowance of Key US Patent Application Covering EDSIVO
GLOBENEWSWIRE
26 Oct 2022
Share Share
Acer Therapeutics` EDSIVO Granted FDA BTD for Vascular Ehlers-Danlos Syndrome

Acer Therapeutics` EDSIVO Granted FDA BTD for Vascular Ehlers-Danlos Syndrome
GLOBENEWSWIRE
04 Apr 2022
Share Share
Acer Therapeutics Restructures Company, Eliminates 29 Employees

Acer Therapeutics Restructures Company, Eliminates 29 Employees
Alex Keown BIOSPACE
08 Jul 2019
Share Share
FDA kicks back Acer`s rare disease drug, demands new test—shares in freefall

FDA kicks back Acer`s rare disease drug, demands new test—shares in freefall
Ben Adams FIERCE BIOTECH
26 Jun 2019
Share Share
FDA rejects Acer`s rare disease drug, asks for new trial

FDA rejects Acer`s rare disease drug, asks for new trial
Natalie Grover ENDPTS
24 Jun 2019
Share Share
FDA accepts Acer, Kala NDAs before funding lapse

FDA accepts Acer, Kala NDAs before funding lapse
Allison Johnson BIOCENTURY
02 Jan 2019
Share Share
Acer Therapeutics Closes $8.15 Million Series B Financing

Acer Therapeutics Closes $8.15 Million Series B Financing
BUSINESS WIRE
10 May 2016
Share Share